Shares of Ipca Laboratories Ltd. gained 2.04%, trading at ₹1,544 on December 19 after a key promoter offloaded a significant stake. The pharmaceutical giant saw increased market activity after the development.
Key Highlights:
- Promoter Stake Sale:
- Usha Madhukar Chandurkar, a promoter of Ipca Laboratories, sold 40 lakh shares, amounting to a 1.6% stake.
- The transaction was valued at ₹600.61 crore, with shares disposed of at an average price of ₹1,501.52 per share.
- Impact on Promoter Holding:
- Post this sale, the promoter group’s holding in Ipca Laboratories reduced from 46.3% to 44.7%.
- Market Response:
- Shares of Ipca Laboratories reacted positively, rising over 2% during the early trading hours.
- The pharmaceutical company continues to attract investor interest despite this strategic divestment.
Additional Information:
- The details of the buyers who acquired these shares in the open market transaction remain undisclosed.
- Ipca Laboratories’ stock performance aligns with sustained investor confidence in the company’s operational stability.
Ipca Laboratories Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
|
Wed, Dec 18 2024
|
₹1,561.40
|
₹1,513.20
|
-2.88%
|
|
Tue, Dec 17 2024
|
₹1,570.80
|
₹1,558.15
|
-0.51%
|
|
Mon, Dec 16 2024
|
₹1,544.40
|
₹1,566.10
|
|
|
Fri, Dec 13 2024
|
₹1,549.70
|
₹1,534.05
|
-1.69%
|
|
Thu, Dec 12 2024
|
₹1,562.00
|
₹1,560.50
|
|
|
Wed, Dec 11 2024
|
₹1,542.00
|
₹1,552.20
|
|
|
Tue, Dec 10 2024
|
₹1,517.85
|
₹1,534.35
|
|
|
Mon, Dec 9 2024
|
₹1,527.50
|
₹1,523.75
|
-0.94%
|
